Revvity | PKI - Ebit



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 15.07B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


Ebit 更改 日
Agilent USD 399M 46M 2026-03
Align Technology USD 191.32M 13.27M 2026-06
Bio Techne USD 75.49M 21.03M 2026-03
Bio-Rad Laboratories USD 72.6M 750.1M 2026-06
Bruker USD 69.6M 59.4M 2026-06
Celltrion KRW 13.41B 1.33B 2026-03
Charles River Laboratories USD 119.89M 9K 2026-06
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Danaher USD 1.13B 217M 2026-06
Dentsply International USD 84M 52M 2026-06
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Edwards Lifesciences USD 519.5M 4.8M 2026-06
Illumina USD 260M 21M 2026-06
Intuitive Surgical USD 977.6M 117.9M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Kangmei Pharma CNY -12.72M 13.97M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Laboratory Of America USD 456.7M 46.6M 2026-06
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Mesa Laboratories USD 4.45M 2.5M 2024-09
Mettler Toledo International USD 287.55M 53.61M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -173K 990K 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Pharma Mar EUR -1.4M 2.03M 2026-06
Qiagen NV USD 141.4M 44.52M 2026-06
Quest Diagnostics USD 459M 60M 2026-06
Quidel USD -15.3M 12.1M 2026-06
Repligen USD 21.13M 1.15M 2026-06
Revvity USD 126.14M 43.36M 2026-06
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Tilray USD -20.01M 9.34M 2025-09
Waters USD 10M 138M 2026-06
Zealand Pharma A/S -389M 318.05M 2026-03
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03